Aldabagh Noor Hatef (10 results)
- Softcover
Seller: Books Puddle, New York, NY, U.S.A.Books Puddle
Contact seller4-star sellerCondition: New
£ 117.83
£ 2.96 shippingShips within U.S.A.Quantity: 4 available
Condition: New. pp. 216.
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 66.10
£ 59.98 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Design, and Synthesis of Novel Anti - tuberculosis Agents | Design,Synthesis and Anti-tuberculosis Evaluation of Ciprofloxacin-Sulfonamide Conjugates using Hybridization Approach | Noor Hatef Aldabagh (u. a.) | Taschenbuch | 216 S. | Englisch | 2017 | Scholars' Press | EAN 9786202301961 | Verantwortl…iche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
- Softcover
Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
Contact seller5-star sellerCondition: New
£ 134.42
£ 10.00 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Paperback. Condition: Brand New. 216 pages. 8.66x5.91x0.49 inches. In Stock.
- Softcover
Seller: Mispah books, Redhill, SURRE, United KingdomMispah books
Contact seller4-star sellerCondition: New
£ 201.00
£ 25.00 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
paperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
- Softcover
- Print on Demand
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermanyBuchWeltWeit Ludwig Meier e.K.
Contact seller5-star sellerCondition: New
£ 79.34
£ 19.71 shippingShips from Germany to U.S.A.Quantity: 2 available
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Tuberculosis (TB) is an airborne global disease, which is typically caused by the Gram-positive bacterium Mycobacterium tuberculosis (Mtb). It remains to be one of the major infectious diseases globally.Despite 40 years of anti-TB c…hemotherapy, tuberculosis remains one of the leading infectious diseases worldwide. Among the main obstacles to the global control of the disease are the HIV epidemic that has dramatically increased risk for developing active TB, the increasing emergence of multi-drug resistant TB and the recalcitrance of persistent infections to treatment with conventional anti-TB drugs.The situation is exacerbated by the increasing emergence of extensively drug-resistant TB. A potential approach to overcome the resistance problem is to design novel and innovative agents. The development of new antibiotics can be achieved from derivatives of known antimicrobial agents or by identification of novel agents active against previously unexploited targets.Thus, keeping in view the need of novel antibacterial agents with improved antimicrobial profile, and as a part of our ongoing programme on design and discovery of novel pharmacotherapeutic and antimicrobial agents. 216 pp. Englisch.
- Softcover
- Print on Demand
Seller: moluna, Greven, Germanymoluna
Contact seller5-star sellerCondition: New
£ 63.15
£ 41.98 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Aldabagh Noor HatefNoor Aldabagh and Mohammed Hassan are pharmacists Ph.D in pharmaceutical chemistry. They are interesting with researches associated with design and chemical synthesis of novel compoun…ds that targeting specific rec.
- Softcover
- Print on Demand
Seller: Majestic Books, Hounslow, United KingdomMajestic Books
Contact seller4-star sellerCondition: New
£ 121.49
£ 6.50 shippingShips from United Kingdom to U.S.A.Quantity: 4 available
Condition: New. Print on Demand pp. 216.
- Softcover
- Print on Demand
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germanybuchversandmimpf2000
Contact seller5-star sellerCondition: New
£ 79.34
£ 51.41 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Tuberculosis (TB) is an airborne global disease, which is typically caused by the Gram-positive bacterium Mycobacterium tuberculosis (Mtb). It remains to be one of the major infectious diseases globally.Despite 40 years of anti-TB chemo…therapy, tuberculosis remains one of the leading infectious diseases worldwide. Among the main obstacles to the global control of the disease are the HIV epidemic that has dramatically increased risk for developing active TB, the increasing emergence of multi-drug resistant TB and the recalcitrance of persistent infections to treatment with conventional anti-TB drugs.The situation is exacerbated by the increasing emergence of extensively drug-resistant TB. A potential approach to overcome the resistance problem is to design novel and innovative agents. The development of new antibiotics can be achieved from derivatives of known antimicrobial agents or by identification of novel agents active against previously unexploited targets.Thus, keeping in view the need of novel antibacterial agents with improved antimicrobial profile, and as a part of our ongoing programme on design and discovery of novel pharmacotherapeutic and antimicrobial agents.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 216 pp. Englisch.
- Softcover
- Print on Demand
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 80.29
£ 52.87 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Tuberculosis (TB) is an airborne global disease, which is typically caused by the Gram-positive bacterium Mycobacterium tuberculosis (Mtb). It remains to be one of the major infectious diseases globally.Despite 40 years of anti-TB chemot…herapy, tuberculosis remains one of the leading infectious diseases worldwide. Among the main obstacles to the global control of the disease are the HIV epidemic that has dramatically increased risk for developing active TB, the increasing emergence of multi-drug resistant TB and the recalcitrance of persistent infections to treatment with conventional anti-TB drugs.The situation is exacerbated by the increasing emergence of extensively drug-resistant TB. A potential approach to overcome the resistance problem is to design novel and innovative agents. The development of new antibiotics can be achieved from derivatives of known antimicrobial agents or by identification of novel agents active against previously unexploited targets.Thus, keeping in view the need of novel antibacterial agents with improved antimicrobial profile, and as a part of our ongoing programme on design and discovery of novel pharmacotherapeutic and antimicrobial agents.
- Softcover
- Print on Demand
Seller: Biblios, frankfurt am main, HESSE, GermanyBiblios
Contact seller4-star sellerCondition: New
£ 128.17
£ 8.53 shippingShips from Germany to U.S.A.Quantity: 4 available
Condition: New. PRINT ON DEMAND pp. 216.
